HK Stock Market Move | UNISOUND (09678) rose over 10% during trading hours. The company's growth in large-scale business models has been validated. The potential for AI clinical diagnosis and reducing medical insurance costs is significant.

UNISOUND (09678) rose more than 10% intraday, with a 9.52% increase as of the time of writing, at HK$319.6, with a trading volume of HK$338 million. On the news front, Zhongsheng Group released a research report stating that UNISOUND's medical core data has solid industry barriers. The company enters the core diagnosis and treatment scenes through medical large models and various types of agents, establishing cooperation with top tertiary hospitals such as Peking Union Medical College Hospital, Beijing Friendship Hospital, and Hunan Xiangya Hospital, covering 40% of the top 100 tertiary hospitals in the country. The report stated that the cutting-edge and professional assets of Beijing Vastdata Technology in these vertical fields will form the company's core competitive advantage. It will rely on high-quality data training to form an efficient data flywheel. In addition, the high-quality Beijing Vastdata Technology has great application potential in the fields of medical insurance and commercial health insurance premium reduction. The report believes that UNISOUND's revenue will accelerate in the next three years, with projected revenue of RMB 1.236 billion, RMB 1.923 billion, and RMB 2.918 billion in 2025-2027 respectively, with growth rates of 31.6%, 55.6%, and 51.7%, achieving profitability in 2026. Considering the verification of the growth of UNISOUND's large model business and the great potential of AI clinical diagnosis and medical insurance premium reduction applications, the company is given a 2026 PS valuation of 25 times, with a target price of HK$750.58.